Virus-specific CD8+ cytotoxic T lymphocyte (CTL) responses are crucial for controlling the infection of HIV-1 and simian immunodeficiency virus (SIV) (1–3), and therefore, candidates that are capable of inducing robust CTL responses are being widely developed for an effective HIV-1 vaccine. The gene discussed is CD8A; the disease is infection.